Evaluation of the performance of the reduced local lymph node assay for skin sensitization testing

Janine Ezendam*, Andre Muller, Betty C. Hakkert, Henk van Loveren

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The local lymph node assay (LLNA) is the preferred method for classification of sensitizers within REACH. To reduce the number of mice for the identification of sensitizers the reduced LLNA was proposed, which uses only the high dose group of the LLNA. To evaluate the performance of this method for classification, LLNA data from REACH registrations were used and classification based on all dose groups was compared to classification based on the high dose group. We confirmed previous examinations of the reduced LLNA showing that this method is less sensitive compared to the LLNA. The reduced LLNA misclassified 3.3% of the sensitizers identified in the LLNA and misclassification occurred in all potency classes and that there was no clear association with irritant properties. It is therefore not possible to predict beforehand which substances might be misclassified. Another limitation of the reduced LLNA is that skin sensitizing potency cannot be assessed. For these reasons, it is not recommended to use the reduced LLNA as a stand-alone assay for skin sensitization testing within REACH. In the future, the reduced LLNA might be of added value in a weight of evidence approach to confirm negative results obtained with non-animal approaches.
Original languageEnglish
Pages (from-to)66-71
JournalRegulatory Toxicology and Pharmacology
Issue number1
Publication statusPublished - Jun 2013


  • Skin sensitization
  • Reduced local lymph node assay
  • Predictivity

Cite this